Abacus Medicine Pharmaceuticals ApS: Financial statements 2022
CVR: 39192063
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Abacus Medicine Pharmaceuticals ApS (CVR 39192063) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -36,339 and a net result of DKK -4,553,460 compared with DKK 2,778,732 the year before. Equity in the 2022 report amounted to DKK 20,797,410. The solvency ratio was 20.1%.
- Gross Profit
- DKK -36,339
- Profit/Loss
- DKK -4,553,460
- Equity
- DKK 20,797,410
- Total Assets
- DKK 103,223,545
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -36K | -4.6M | 20.8M | 0 |
| 2021 | - | -43K | 2.8M | 25.4M | 0 |
| 2020 | - | -63K | 188K | 22.6M | 0 |
| 2019 | - | -212K | 548K | 15.9M | 0 |
| 2018 | - | -62K | 860K | 15.3M | - |
Official annual report
Keep an eye on Abacus Medicine Pharmaceuticals ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Abacus Medicine Pharmaceuticals ApS has published its annual report for 2021. Gross profit came to DKK -43,133, and the net result was DKK 2,778,732.
About Abacus Medicine Pharmaceuticals ApS
Abacus Medicine Pharmaceuticals ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2017. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Abacus Medicine Pharma Services ApS and Aposave ApS. The management consists of Flemming Wagner. The company is owned by ABACUS MEDICINE A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -80,000 and a net result of DKK -5,483,000 compared with DKK -2,436,000 the year before. Equity in the 2025 report amounted to DKK 14,264,000.